The New NIH and FDA Medical Research Policies: A Model of Policy Streams or Advocacy Coalitions?

NIH 和 FDA 的新医学研究政策：政策流模式还是倡导联盟模式？

• 批准号: 9710035
• 负责人: Karen Baird
• 金额: $ 1.8万
• 依托单位: SUNY College at Purchase
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-06-01 至 1998-12-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=9710035&HistoricalAwards=false
• 关键词: New; NIH; FDA; Medical; Research

For many years women were excluded from or underrepresented in clinical research studies. In the early 1990s federal policies governing women and medical research were revised. Two agencies, NIH and the FDA, took the federal guidelines and implemented very different and distinctive policies governing the representation of women in clinical studies. This research focuses on why different policy regulations were adopted by these agencies. In the detailed case studies that are produced, two distinct models of policy making are tested. Each model offers specific predictions concerning when alternative paths are taken by agencies. This research provides a greater understanding of those factors that influence public policy, the procedures by which they are developed and the specification of alternative policy options within the U.S. political system.

多年来，妇女在临床研究中被排除在或人为不足。 在1990年代初期，对妇女的联邦政策进行了修订。 两个机构NIH和FDA采用了联邦准则，并实施了策略中妇女在临床研究中代表的非常不同和独特的政策。 这项研究重点介绍了为什么这些机构采用不同的政策法规。 在生产的详细案例研究中，测试了两个不同的政策制定模型。 每个模型都提供有关代理机构何时采取替代路径的特定预测。 这项研究对影响公共政策，开发程序的程序以及美国政治体系中替代政策选择的规范提供了更深入的了解。